US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Class II · Moderate risk Terminated

PROBLEND Hand Sanitizer

Reason CGMP Deviations: deficiencies were identified during an FDA inspection of Seatex's manufacturing facility.

Seatex LLC D-0360-2024
Class II · Moderate risk Terminated

7 Eleven Hand Sanitizer Gel

Reason CGMP Deviations: deficiencies were identified during an FDA inspection of Seatex's manufacturing facility.

Seatex LLC D-0359-2024
Class II · Moderate risk Terminated

7 Eleven FOR GAS ISLAND USE ONLY

Reason CGMP Deviations: deficiencies were identified during an FDA inspection of Seatex's manufacturing facility.

Seatex LLC D-0358-2024
Class II · Moderate risk Terminated

PROBLEND E3 Foaming Hand Sanitizer

Reason CGMP Deviations: deficiencies were identified during an FDA inspection of Seatex's manufacturing facility.

Seatex LLC D-0357-2024
Class II · Moderate risk Ongoing

Broncochem Cold & Tea

Reason Stability testing failures for one or two of the four active pharmaceutical ingredients among the finished drug products, i.e., Phenylephrine HCL, and/or Chlorpheniramine Maleate.

Global Corporation NDC 65131-097-12 D-0387-2024
Class II · Moderate risk Ongoing

Broncochem Cold & Flu Syrup Kids

Reason Stability testing failures for one or two of the four active pharmaceutical ingredients among the finished drug products, i.e., Phenylephrine HCL, and/or Chlorpheniramine Maleate.

Global Corporation NDC 65131-098-44 D-0386-2024
Class II · Moderate risk Ongoing

Fluticasone Propionate Nasal Spray USP

Reason CGMP Deviations:Suspected potential presence of Burkholderia cepacia complex

Golden State Medical Supply Inc. NDC 60429-195-15 D-0349-2024
Class II · Moderate risk Terminated

Oseltamivir Phosphate for Oral Suspension 6mg/ml

Reason Failed Impurities/Degradation Specifications: Out-of-specification test results.

Amneal Pharmaceuticals of New York, LLC NDC 69238-1273-6 D-0327-2024
Class II · Moderate risk Ongoing

Clobazam Tablets 10mg

Reason CGMP Deviations: Out of specification for residual solvents.

Micro Labs Limited NDC 42571-315-01 D-0348-2024
Class II · Moderate risk Terminated

Cabtreo

Reason CGMP Deviations: Product was stored outside labeled storage temperature requirements. Product was exposed to controlled room temperature environment instead of remaining refrigerated.

Mckesson Corporation NDC 0187-0006-25 D-0347-2024
Class II · Moderate risk Terminated

Telmisartan Tablets

Reason Failed Stability Specifications: Out of specification for blend uniformity.

Micro Labs Limited NDC 42571-227-30 D-0388-2024
Class II · Moderate risk Terminated

HydrALAZINE Hydrochloride Tablets

Reason an out of specification result obtained during routine stability testing for Impurities. There is a remote possibility that use of this product could cause a medically reversible or transient adverse health consequences.

The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories NDC 0904-6440-61 D-0324-2024
Class II · Moderate risk Terminated

Bicillin L-A

Reason cGMP Deviations: Products were stored outside the drug label specifications.

Mckesson Medical-Surgical Inc. Corporate Office NDC 60793-0701-10 D-0373-2024
Class II · Moderate risk Terminated

Infuvite Adult Multiple vitamins injection

Reason cGMP Deviations: Products were stored outside the drug label specifications.

Mckesson Medical-Surgical Inc. Corporate Office NDC 54643-5649-01 D-0372-2024
Class II · Moderate risk Terminated

Rocuronium Bromide Injection

Reason cGMP Deviations: Products were stored outside the drug label specifications.

Mckesson Medical-Surgical Inc. Corporate Office NDC 55150-226-10 D-0371-2024
Class II · Moderate risk Ongoing

Terlivaz

Reason cGMP deviations: Temperature excursion due to shipping delay from manufacturer to distributor. Affected distributor has been notified.

Mallinckrodt Hospital Products Inc. NDC 43825-200-01 D-0341-2024
Class II · Moderate risk Ongoing

Acthar Gel

Reason cGMP deviations: Temperature excursion due to shipping delay from manufacturer to distributor. Affected distributor has been notified.

Mallinckrodt Hospital Products Inc. NDC 63004-8710-1 D-0340-2024
Class II · Moderate risk Ongoing

Mesalamine Extended-Release Capsules

Reason Failed Dissolution Specifications: Out of specification for dissolution.

Sun Pharmaceutical Industries INC NDC 63304-089-13 D-0350-2024
Class II · Moderate risk Terminated

Voriconazole for Oral Suspension

Reason Labeling: Incorrect or Missing Package Insert

Lupin Pharmaceuticals Inc. D-0337-2024
Class II · Moderate risk Terminated

Lansoprazole Delayed-Release Capsules USP

Reason CGMP Deviations: Inadequate induction sealing on bottles, capsules were observed with bubbles on band seal, capsules with holes and spheres sticking to capsules. Also coding details were missing on one bottle.

NATCO Pharma Limited NDC 16571-742-41 D-0318-2024
Class II · Moderate risk Ongoing

Lubricant PM Ointment

Reason Lack of Assurance of Sterility

Brassica Pharma Pvt Ltd NDC 71406-124-35 D-0354-2024
Class II · Moderate risk Ongoing

CVS Health Lubricant Eye Ointment

Reason Lack of Assurance of Sterility

Brassica Pharma Pvt Ltd NDC 76168-707-35 D-0353-2024